TCIM
KYNB

TIAA CREF Investment Management’s Kyntra Bio KYNB Stock Holding History

TIAA CREF Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$13.5M Sell
9,903
-7
-0.1% -$9.49K 0.01% 897
2018
Q4 		$11.5M Sell
9,910
-472
-5% -$531K 0.01% 890
2018
Q3 		$15.8M Sell
10,382
-1,545
-13% -$2.38M 0.01% 852
2018
Q2 		$18.7M Buy
11,927
+820
+7% +$1.07M 0.01% 779
2018
Q1 		$12.8M Sell
11,107
-590
-5% -$777K 0.01% 974
2017
Q4 		$13.9M Sell
11,697
-926
-7% -$1.16M 0.01% 961
2017
Q3 		$17M Buy
12,623
+363
+3% +$383K 0.01% 840
2017
Q2 		$9.9M Buy
12,260
+1,750
+17% +$1.22M 0.01% 1141
2017
Q1 		$6.48M Sell
10,510
-305
-3% -$186K ﹤0.01% 1417
2016
Q4 		$5.79M Buy
10,815
+826
+8% +$412K ﹤0.01% 1501
2016
Q3 		$5.17K Sell
9,989
-25
-0.2% -$11.8K ﹤0.01% 1588
2016
Q2 		$4.11M Buy
10,014
+508
+5% +$233K ﹤0.01% 1684
2016
Q1 		$5.06M Buy
9,506
+203
+2% +$101K ﹤0.01% 1501
2015
Q4 		$7.09M Sell
9,303
-2,041
-18% -$1.35M 0.01% 1303
2015
Q3 		$6.22M Buy
11,344
+1,765
+18% +$1.07M ﹤0.01% 1388
2015
Q2 		$5.63M Buy
9,579
+7,748
+423% +$4.51M ﹤0.01% 1592
2015
Q1 		$1.44M Buy
1,831
+1,127
+160% +$874K ﹤0.01% 2432
2014
Q4 		$481K Buy
+704
New +$453K ﹤0.01% 2976

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TIAA CREF Investment Management's KYNB Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Kyntra Bio (KYNB) stake by 0.07% in Q1 2019, selling an estimated $9.49K and leaving 9,903 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #897.

TIAA CREF Investment Management first reported a position in KYNB in Q4 2014 and has held it in 18 quarters since. The position peaked at $18.7M in Q2 2018. 225 funds tracked by Wall St. Rank hold KYNB as of Q1 2019.

  • TIAA CREF Investment Management held 9,903 shares of Kyntra Bio worth $13.5M as of Q1 2019.
  • TIAA CREF Investment Management sold 7 Kyntra Bio shares in Q1 2019, an estimated $9.49K.
  • Kyntra Bio made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #897 holding.
  • TIAA CREF Investment Management first reported a position in Kyntra Bio in Q4 2014 and has held it in 18 quarters since.
  • TIAA CREF Investment Management's Kyntra Bio position peaked at $18.7M in Q2 2018.
  • 225 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.